Immunotherapy for bone cancer

Bone cancer refers to a malignant tumor that occurs in bones or their associated blood vessels, nerves, bone marrow and other tissues. It can be primary or secondary. The cause of bone cancer is the same as tumors in other parts of the body. It is not clear whether it is caused or not. The treatment methods are nothing more than surgery, radiotherapy and chemotherapy. In addition, it can also be supplemented with vascular embolization therapy, heat therapy, traditional Chinese medicine treatment and immunotherapy.

The biggest advantage of tumor immunotherapy is that it targets tumor cells. Even non-specific killer cells such as natural killer cells are much more effective at killing tumor cells than normal cells. This is extremely valuable for patients whose immune function has been compromised and who need radiotherapy and chemotherapy. After years of basic and clinical experimental research, tumor immunotherapy has made great progress and presents an attractive development prospect.

The main purpose of bone cancer treatment is to preserve limb function as much as possible and maintain the normal structure of bones and joints on the basis of saving the patient's life, that is, to minimize the impact on the patient's quality of life. The development of artificial joint prostheses and the combined use of radiation, chemotherapy, immunotherapy and other methods have made limb-saving surgery possible. Choosing a surgery that can completely remove the tumor and preserve or reconstruct limb function has become the main development direction of bone cancer surgical treatment.